carbamazepine has been researched along with Jaundice, Neonatal in 3 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Jaundice, Neonatal: Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of transient cholestatic hepatitis occurring in an infant between the third and seventh weeks of life, most likely due to carbamazepine exposure during pregnancy and breast feeding." | 7.71 | Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. ( Braegger, CP; Frey, B; Ghelfi, D, 2002) |
| "We report a 3-week-old boy with cholestatic hepatitis, most likely due to carbamazepine exposure during pregnancy and breastfeeding." | 7.68 | Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. ( Frey, B; Musy, JP; Schubiger, G, 1990) |
| "To report a case of transient cholestatic hepatitis occurring in an infant between the third and seventh weeks of life, most likely due to carbamazepine exposure during pregnancy and breast feeding." | 3.71 | Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. ( Braegger, CP; Frey, B; Ghelfi, D, 2002) |
| "We report a 3-week-old boy with cholestatic hepatitis, most likely due to carbamazepine exposure during pregnancy and breastfeeding." | 3.68 | Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. ( Frey, B; Musy, JP; Schubiger, G, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, B | 2 |
| Braegger, CP | 1 |
| Ghelfi, D | 1 |
| Merlob, P | 1 |
| Mor, N | 1 |
| Litwin, A | 1 |
| Schubiger, G | 1 |
| Musy, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency[NCT01379469] | Phase 2 | 20 participants (Actual) | Interventional | 2012-01-31 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for carbamazepine and Jaundice, Neonatal
| Article | Year |
|---|---|
Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding.
Topics: Breast Feeding; Carbamazepine; Chemical and Drug Induced Liver Injury; Cholestasis; Epilepsy; Female | 2002 |
Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding.
Topics: Adult; Breast Feeding; Carbamazepine; Epilepsy; Female; gamma-Glutamyltransferase; Humans; Infant, N | 1992 |
Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding.
Topics: Breast Feeding; Carbamazepine; Chemical and Drug Induced Liver Injury; Epilepsy; Female; Humans; Inf | 1990 |